Analyst Comments
Provided by:
Set Up E-mail Alerts For Analyst Comments »
The top source for Wall Street analyst comments, price target and estimate changes, and speculation.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
-
Jefferies Reiterates Buy Rating on Alcoa (AA)
-
Goldman Sachs Reiterates Neutral Rating on Sarepta Therapeutics (SRPT)
-
William Blair on Sarepta Therapeutics (SRPT): 'we continue to view the stock’s near-term upside potential as limited'
-
-
-
-
-
-
-
MaxLinear (MXL) PT Raised to $18 at Stifel
-
-
-
-
-
-
-
Astera Labs (ALAB) PT Raised to $110 at Stifel
-
-
-
-
-
-
-
Kinder Morgan (KMI) PT Raised to $28 at Scotiabank
-
-
-
-
-
-
-
Netflix (NFLX) PT Raised to $1,515 at Rosenblatt
-
-
-
-
-
-
-
Cantor Fitzgerald on Booz Allen Hamilton (BAH): ' Move to Top GovTech Pick'
-
-
-
-
-
-
-
Six Flags Entertainment (FUN) PT Lowered to $36 at Mizuho
-
-
-
-
-
424,405 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Analyst Comments reports.